Preferential expression of AChR epsilon-subunit in thymomas from patients with myasthenia gravis.

Preferential expression of AChR epsilon-subunit in thymomas from patients with myasthenia gravis.

The role of antigen expression by thymomas in myasthenia gravis (MG) is not clear. Previous reports of acetylcholine receptor (AChR) mRNA expression by the highly sensitive reverse transcription-polymerase chain reactions (RT-PCR) produced varying results. To try to clarify this issue, we first used...

書誌詳細
主要な著者:	Maclennan, C, Vincent, A, Marx, A, Willcox, N, Gilhus, N, Newsom-Davis, J, Beeson, D
フォーマット:	Journal article
言語:	English
出版事項:	2008

類似資料

Myasthenia gravis in a woman with congenital AChR deficiency due to epsilon-subunit mutations.
著者:: Croxen, R, 等
出版事項: (2002)

Antibodies to AChRs in seronegative myasthenia gravis
著者:: Leite, M, 等
出版事項: (2006)

Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures.
著者:: Farrugia, M, 等
出版事項: (2007)

Congenital myasthenic syndrome patients due to AChR epsilon subunit mutations
著者:: Bonifati, D, 等
出版事項: (2004)

Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.
著者:: Mygland, A, 等
出版事項: (2000)

End-plate gamma- and epsilon-subunit mRNA levels in AChR deficiency syndrome due to epsilon-subunit null mutations.
著者:: Croxen, R, 等
出版事項: (2001)

Splice-site mutations in the achr epsilon subunit gene associated with congenital myasthenic syndrome
著者:: Croxen, R, 等
出版事項: (2000)

Thymoma and paraneoplastic myasthenia gravis.
著者:: Marx, A, 等
出版事項: (2010)

AChR deficiency due to epsilon-subunit mutations: two common mutations in the Netherlands.
著者:: Faber, C, 等
出版事項: (2009)

Correlation between polymorphisms in the AChR gamma and delta subunit promoters and clinical phenotype in AChR deficiency patients
著者:: Bonifati, D, 等
出版事項: (2004)

Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK.
著者:: Vuslat Yilmaz, 等
出版事項: (2015-01-01)

Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis
著者:: Lee, J, 等
出版事項: (2016)

Nomogram for short-term outcome assessment in AChR subtype generalized myasthenia gravis
著者:: Rui Zhao, 等
出版事項: (2021-06-01)

Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis.
著者:: Buckley, C, 等
出版事項: (2001)

Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient
著者:: Saxena, A, 等
出版事項: (2017)

Lack of association between acetylcholine receptor epsilon polymorphisms and early-onset myasthenia gravis.
著者:: Bonifati, D, 等
出版事項: (2004)

A Stable Cell Line Expressing Clustered AChR: A Novel Cell-Based Assay for Anti-AChR Antibody Detection in Myasthenia Gravis
著者:: Yu Cai, 等
出版事項: (2021-07-01)

Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
著者:: Deymeer, F, 等
出版事項: (2007)

The clinical outcome in AChR-positive generalized myasthenia gravis: A retrospective observational study
著者:: Pawan T Ojha, 等
出版事項: (2023-01-01)

Direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patients.
著者:: Gregory Kordas, 等
出版事項: (2014-01-01)

The association of PTPN22 R620W polymorphism is stronger with late-onset AChR-myasthenia gravis in Turkey.
著者:: Gizem A Kaya, 等
出版事項: (2014-01-01)

Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort
著者:: Antonino Lupica, 等
出版事項: (2022-04-01)

Correction: Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients.
著者:: PLOS ONE Staff
出版事項: (2015-01-01)

Correction: direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patients.
著者:: PLOS ONE Staff
出版事項: (2015-01-01)

Oral Microbiota Profile in a Group of Anti-AChR Antibody–Positive Myasthenia Gravis Patients
著者:: Chao Huang, 等
出版事項: (2022-07-01)

A cysteine residue close to the C-terminus of the E subunit is essential for surface acetylcholine receptor (AChR) expression: Implications for AChR deficiency syndrome
著者:: Ealing, J, 等
出版事項: (2002)

Selective silencing of pathogenic a subunit AChR mutant in dominant disorders
著者:: Abdelgany, A, 等
出版事項: (2004)

Autoantibody of NRIP, a novel AChR‐interacting protein, plays a detrimental role in myasthenia gravis
著者:: Li‐Kai Tsai, 等
出版事項: (2021-06-01)

Clinical outcomes in AchR antibody-positive myasthenia gravis: Where does rituximab stand in the current times?
著者:: Megha Chetan Dhamne
出版事項: (2023-01-01)

Mutations in congenital myasthenic syndromes reveal an epsilon subunit C-terminal cysteine, C470, crucial for maturation and surface expression of adult AChR.
著者:: Ealing, J, 等
出版事項: (2002)

Neuromyotonia and myasthenia gravis without thymoma.
著者:: Van Parijs, V, 等
出版事項: (2002)

Slow‐channel myasthenia due to novel mutation in M2 domain of AChR delta subunit
著者:: Xin‐Ming Shen, 等
出版事項: (2019-10-01)

Ocular myasthenia gravis and thymoma
著者:: Victor Alegre-Ituarte, 等
出版事項: (2022-09-01)

AChR phosphorylation and indirect inhibition of AChR function in seronegative MG.
著者:: Plested, C, 等
出版事項: (2002)

Consensus recommendation for the treatment of generalised Myasthenia Gravis with anti-acetylcholine receptor antibodies (gMG AChR+) in Spain
著者:: Elena Cortés-Vicente, 等
出版事項: (2025-01-01)

Short-term and long-term prognoses in AChR-Ab positive very-late-onset myasthenia gravis patients
著者:: Nairong Xie, 等
出版事項: (2025-01-01)

Mutation in the AChR ion channel gate underlies a fast channel congenital myasthenic syndrome.
著者:: Webster, R, 等
出版事項: (2004)

Discovery of functionally distinct anti-C7 monoclonal antibodies and stratification of anti-nicotinic AChR positive Myasthenia Gravis patients
著者:: Eleonora Lekova, 等
出版事項: (2022-09-01)

Clinical Characteristics and Prognosis of Anti-AChR Positive Myasthenia Gravis Combined With Anti-LRP4 or Anti-Titin Antibody
著者:: Yuping Chen, 等
出版事項: (2022-05-01)

Structural abnormalities of the AChR caused by mutations underlying congenital myasthenic syndromes.
著者:: Beeson, D, 等
出版事項: (2003)